UNSPSC 85502126: Supplement left internal mammary artery with synthetic substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left internal mammary artery with synthetic substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03U13JZ

UNSPSC 85502126 Supplement left internal mammary artery with synthetic substitute, percutaneous approach is a Commodity code that shows no active state and local procurement aligned with its medical device scope; instead, recent opportunities tagged under this code reflect broad healthcare administration, occupational medicine, and staffing services unrelated to cardiovascular surgical implants.

The six most recent state and local opportunities solicited under this code include independent medical evaluation services for public safety pension disability determinations (City of Phoenix Retirement Office, RFP due October 16, 2026); surgical benefit carve-out programs for employee health plans (City of Long Beach, RFP due October 7, 2026); occupational medical surveillance for ferry system workers (Washington State Department of Transportation, RFP due October 9, 2026); emergency and specialty medical services for youth in custody (Harris County Juvenile Probation Department, RFI due September 25, 2026); pharmacy benefit management services (Collier County, RFP due April 9, 2026); and temporary health professional staffing across ancillary clinical specialties (County of Santa Clara Health System, RFP due October 7, 2026). The issuing bodies span state departments, county governments, and municipal agencies, with activity concentrated in Arizona, California, Florida, and Washington. The code classification appears misaligned with its nominal scope — no recent opportunities reflect procurement of left internal mammary artery grafts or related cardiovascular implants. Vendors pursuing activity under this code should verify alignment with the issuing body's actual service or product category before pursuing listed opportunities.